GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Excelsior Biopharma 6496.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

23.85

+3.47%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 898.3m

FY2016FY2025

Net income

−TWD 183.2m

FY2016FY2025

Free cash flow

−TWD 175.7m

FY2016FY2025

Shareholders' equity

TWD 804.2m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 898.3mTWD 861.9mTWD 771.6mTWD 671.8mTWD 1.34bnTWD 1.44bnTWD 1.54bnTWD 1.69bnTWD 1.72bnTWD 1.54bn
Research and developmentTWD 96.1mTWD 83.6mTWD 62.5mTWD 42.3mTWD 56.0mTWD 57.3mTWD 51.5mTWD 39.4mTWD 60.4mTWD 66.0m
Operating income−TWD 174.2m−TWD 82.8m−TWD 80.8m−TWD 25.8m−TWD 1.0mTWD 46.8mTWD 86.8mTWD 282.1mTWD 325.8mTWD 215.5m
Net income−TWD 183.2m−TWD 98.7m−TWD 91.0m−TWD 33.8m−TWD 15.6mTWD 35.3mTWD 71.0mTWD 221.8mTWD 279.7mTWD 180.5m
Diluted earnings per share-4.02-2.17-1.94-0.72-0.340.761.564.876.143.85

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 1.48bnTWD 1.58bnTWD 1.58bnTWD 1.71bnTWD 1.84bnTWD 1.90bnTWD 1.50bnTWD 1.64bnTWD 1.68bnTWD 1.53bn
Cash and short-term investments——TWD 589.9mTWD 1.11bnTWD 1.10bnTWD 1.15bn———TWD 768.6m
Total liabilitiesTWD 679.8mTWD 586.9mTWD 472.9mTWD 507.5mTWD 608.9mTWD 617.1mTWD 244.1mTWD 270.9mTWD 339.4mTWD 283.2m
DebtTWD 110.0mTWD 110.0mTWD 377.4mTWD 375.8mTWD 397.2mTWD 395.4m———TWD 50.0m
Shareholders' equityTWD 804.2mTWD 991.5mTWD 1.10bnTWD 1.21bnTWD 1.23bnTWD 1.28bnTWD 1.25bnTWD 1.37bnTWD 1.34bnTWD 1.25bn
Shares outstanding46m46m47m47m47m47m46m46m46m47m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−TWD 138.7m−TWD 99.8m−TWD 134.8mTWD 5.5mTWD 55.8mTWD 520.8m−TWD 169.7mTWD 126.9mTWD 349.5mTWD 193.0m
Capital spending−TWD 36.9m−TWD 257.1m−TWD 35.7m−TWD 7.8m−TWD 2.9m−TWD 11.6m−TWD 20.4m−TWD 9.5m−TWD 18.1m−TWD 15.0m
Free cash flow−TWD 175.7m−TWD 356.9m−TWD 170.4m−TWD 2.3mTWD 52.9mTWD 509.2m−TWD 190.1mTWD 117.4mTWD 331.4mTWD 178.0m
Dividends paid————−TWD 46.7m−TWD 46.7m−TWD 186.7m−TWD 186.7m−TWD 186.7m−TWD 116.7m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 232.5mTWD 218.1mTWD 279.2mTWD 207.1mTWD 202.0mTWD 209.9mTWD 240.7mTWD 218.2m
Operating income−TWD 57.9m−TWD 52.3m−TWD 35.9m−TWD 51.1m−TWD 48.7m−TWD 38.2m−TWD 15.0m−TWD 17.4m
Net income−TWD 57.5m−TWD 54.7m−TWD 39.3m−TWD 55.1m−TWD 47.9m−TWD 40.9m−TWD 21.8m−TWD 22.3m
Diluted earnings per share-1.26-1.20-0.86-1.19-1.05-0.90-0.48-0.49
Cash from operations−TWD 20.0m−TWD 40.0m−TWD 22.0m—TWD 3.0m−TWD 54.0m−TWD 40.0m−TWD 40.0m
Capital spending−TWD 3.0m−TWD 1.0m−TWD 1.0m—−TWD 14.0m−TWD 12.0m−TWD 32.0m−TWD 20.0m
Free cash flow−TWD 23.0m−TWD 41.0m−TWD 23.0m—−TWD 11.0m−TWD 66.0m−TWD 72.0m−TWD 60.0m
Total assetsTWD 1.42bnTWD 1.43bnTWD 1.48bn—TWD 1.42bnTWD 1.47bnTWD 1.58bnTWD 1.58bn
DebtTWD 108.7mTWD 110.0mTWD 110.0m—TWD 110.0mTWD 110.0mTWD 110.0mTWD 110.0m
Shareholders' equityTWD 689.0mTWD 745.8mTWD 804.2m—TWD 896.8mTWD 949.4mTWD 991.5mTWD 1.02bn

Financial ratios

Data as of 4 Nov 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin-18.3%-9.2%-9.7%-3.8%-0.1%3.2%
Net margin-20.4%-11.5%-11.8%-5.0%-1.2%2.4%
Return on equity-22.8%-10.0%-8.2%-2.8%-1.3%2.8%
Return on assets-12.3%-6.3%-5.8%-2.0%-0.9%1.9%
Free cash flow yield—14.9%-9.1%1.2%5.4%49.2%
Revenue growth4.2%11.7%14.9%-49.8%-7.3%-6.3%
Earnings growth85.6%8.5%169.6%115.7%-144.3%-50.3%
Current ratio1.95x3.43x5.92x3.15x6.12x6.53x
Debt to equity0.14x0.11x0.07x0.28x0.28x0.25x
Equity ratio54.2%62.8%70.0%70.4%66.9%67.5%
Interest coverage-21.19x-9.89x-11.72x-5.82x-0.22x22.10x
R&D as a share of sales10.7%9.7%8.1%6.3%4.2%4.0%
Buybacks as a share of market value—2.8%-0.3%-0.0%0.0%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue10.2%-9.1%-3.2%
Operating income89.0%——
Net income75.7%——

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-14.6%-11.3%-5.3%5.6%
Net margin-16.0%-12.7%-6.5%3.7%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-7.3-13.8-14.8-38.5-87.239.222.98.312.016.4
Price to sales1.51.61.81.91.01.01.11.12.01.9

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.